Who owns ALZAMEND NEURO INC COM NEW 2025?
- Ticker: ALZN
- CUSIP Number: 02262m605
Tip: Access positions for across all investors
Analyze quarterly positions in Alzamend Neuro Inc Com New 2025 with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Alzamend Neuro Inc Com New 2025 stock
Who bought or sold ALZAMEND NEURO INC COM NEW 2025 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DRW Holdings | 116k | $212k | 27% | Dec 2025 |
|
| Geode Capital Management | 28k | $50k | 34% | Dec 2025 |
|
| UBS Group | 25k | $45k | 1084% | Dec 2025 |
|
| Vanguard Group | 22k | $39k | 0% | Dec 2025 |
|
| Virtu Financial | 13k | $23k | 100% | Dec 2025 |
|
| XTX Topco | 13k | $23k | 100% | Dec 2025 |
|
| Hartland & Co | 10k | $18k | 0% | Dec 2025 |
|
| Tower Research Capital | 2.1k | $3.8k | 30% | Dec 2025 |
|
| BlackRock | 437.00 | $794.990400 | 0% | Dec 2025 |
|
| SBI Securities | 22.00 | $40.000400 | 0% | Dec 2025 |
|
| Harbor Investment Advisory | 1.00 | $2.000000 | 0% | Dec 2025 |
|